Published in Semin Arthritis Rheum on February 01, 1988
Primary hypertrophic osteoarthropathy with myelofibrosis. Rheumatol Int (2007) 1.42
Bone abnormalities and severe arthritis in pachydermoperiostosis. Ann Rheum Dis (1992) 1.13
Pachydermoperiostosis-critical analysis with report of five unusual cases. Eur J Pediatr (2007) 1.01
Hypertrophic pulmonary osteoarthropathy (HPOA) (Pierre Marie-Bamberger syndrome): two cases presenting as acute inflammatory arthritis. Description and review of the literature. Rheumatol Int (2006) 1.00
Primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report. Rheumatol Int (2006) 0.85
Hypertrophic osteoarthropathy following aortic surgery. Ann Rheum Dis (1996) 0.75
Tc-99m MDP bone scintigraphy in a case of Touraine-Solente-Gole syndrome. Indian J Nucl Med (2011) 0.75
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Detection of preinvasive cancer cells. Nature (2000) 3.20
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
The effectiveness of a nurse practitioner in screening patients in a spinal disorders clinic. Spine (Phila Pa 1976) (1988) 2.41
The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther (1970) 2.23
The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther (1994) 2.11
Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest (1991) 2.04
Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol (2000) 2.03
The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol (1976) 1.93
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
Use of gallium to treat Paget's disease of bone: a pilot study. Lancet (1990) 1.93
Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol (1997) 1.84
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis. J Clin Invest (1975) 1.62
Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. Drug Metab Dispos (1998) 1.57
Medical histories may be unreliable in screening volunteers for clinical trials. Clin Pharmacol Ther (1996) 1.49
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis Rheum (1999) 1.47
Infliximab in active early rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
Nitrite in human saliva. Its possible relationship to nitrosamine formation. J Natl Cancer Inst (1974) 1.46
Neuroarthropathy associated with chronic alcoholism. AJR Am J Roentgenol (1988) 1.45
Chondrex: new marker of joint disease. Clin Chem (1998) 1.43
Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy. Clin Rheumatol (2015) 1.43
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. Res Commun Chem Pathol Pharmacol (1972) 1.38
Reye-like syndrome associated with valproic acid therapy. J Pediatr (1979) 1.38
Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol (1993) 1.30
Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers. Br J Clin Pharmacol (2000) 1.28
Clinical effects and pharmacokinetics of racemic methadone and its optical isomers. Clin Pharmacol Ther (1977) 1.21
Noninvasive cerebrovascular assessment of Takayasu arteritis. Stroke (2000) 1.17
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum (1999) 1.16
Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro. J Pharmacol Exp Ther (1971) 1.11
Studies on the comparative pharmacology and selective toxicity of tricaine methanesulfonate: metabolism as a basis of the selective toxicity in poikilotherms. J Pharmacol Exp Ther (1976) 1.07
Primary health care in marginal urban areas: the Costa Rican model. Bull Pan Am Health Organ (1984) 1.07
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group. J Rheumatol (1999) 1.04
Quality-adjusted life years lost to arthritis: effects of gender, race,and social class. Arthritis Care Res (1996) 1.03
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Takayasu's arteritis in children. J Rheumatol (1991) 0.99
Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers. Ann Intern Med (1972) 0.98
Intradermal tophi in gout: a case-control study. J Rheumatol (1999) 0.97
Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis. J Rheumatol (2000) 0.96
Studies on the metabolism of diphenylhydantoin in mice. J Pharmacol Exp Ther (1969) 0.96
X-ray structure of glial cell-derived neurotrophic factor at 1.9 A resolution and implications for receptor binding. Nat Struct Biol (1997) 0.95
Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation (1996) 0.95
Vertebral involvement in calcium pyrophosphate dihydrate crystal deposition disease. Radiographic-pathological correlation. Radiology (1984) 0.94
Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. Circulation (1999) 0.94
Transmission of valproic acid (Depakene) across the placenta: half-life of the drug in mother and baby. J Pediatr (1979) 0.93
Predicting health care use among older osteoarthritis patients in an HMO. Arthritis Care Res (1995) 0.93
Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. J Pharmacol Exp Ther (1979) 0.92
Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. J Chromatogr A (2004) 0.92
Excretion of valproic acid into semen of rabbits and man. Epilepsia (1978) 0.91
Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Mutat Res (1999) 0.91
Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res (Hoboken) (2014) 0.90
Anesthetic effects and elimination of tricaine methanesulphonate (MS-222) in terrestial vertebrates. Comp Biochem Physiol C (1976) 0.90
Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Clin Pharmacol Ther (1997) 0.89
Diagnosis of tarsal coalition with computed tomography. Clin Orthop Relat Res (1986) 0.89
Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial. Gynecol Oncol (2005) 0.88
Carpal alterations in adult-onset Still disease, juvenile chronic arthritis, and adult-onset rheumatoid arthritis: comparative study. Radiology (1987) 0.88
A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. J Pharmacol Exp Ther (1991) 0.88
Drug interactions with cimetidine: an update. Pharmacol Ther (1985) 0.88
Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int (1992) 0.86
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology (Oxford) (2001) 0.85
Simultaneous heart rate variability and polysomnographic analyses in fibromyalgia. Clin Exp Rheumatol (2003) 0.85
Intoxication with 5,5-diphenylhydantoin (Dilantin): clinical features, blood levels, urinary metabolites, and metabolic changes in a child. J Pediatr (1972) 0.85
The excretion of caffeine in the semen of men: pharmacokinetics and comparison of the concentrations in blood and semen. J Clin Pharmacol (1984) 0.84
Osteoarthritis of the glenohumeral joint: a radiologic-pathologic study. AJR Am J Roentgenol (1985) 0.84
Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry. Drug Metab Dispos (1987) 0.84
A rapid method for the mass spectrometric identification of glucuronides and other polar drug metabolites in permethylated rat bile. Drug Metab Dispos (1974) 0.84
Induction of fluconazole metabolism by rifampin: in vivo study in humans. J Clin Pharmacol (1991) 0.84
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Res (2001) 0.84
Reaction of nitrite with ascorbate and its relation to nitrosamine formation. J Natl Cancer Inst (1975) 0.83
Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers. Br J Clin Pharmacol (1995) 0.83
Spanish LupusPRO: cross-cultural validation study for lupus. Lupus (2013) 0.83
Reliability of ultrasonography in detecting shoulder disease in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.83
Effect of sertraline on protein binding of warfarin. Clin Pharmacokinet (1997) 0.83
Development of an auditory implant manipulator for minimally invasive surgical insertion of implantable hearing devices. J Laryngol Otol (2010) 0.83
[Influence of aluminium- and magnesium hydroxide (Alucol) on cortisone absorption]. Schweiz Med Wochenschr (1973) 0.82
[Eye complications in chronic juvenile arthritis]. Klin Monbl Augenheilkd (1993) 0.82
Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis. J Rheumatol (1988) 0.82
Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis. Gut (2006) 0.82
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus (2009) 0.82
Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils. Biochem Pharmacol (1995) 0.82
The metabolic fate of hexobarbital in the rat. J Pharmacol Exp Ther (1974) 0.82
Utilization of intravenous dihydroxypropyl theophylline (dyphylline) in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline. J Allergy Clin Immunol (1980) 0.82
Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics. Clin Pharmacol Ther (1986) 0.82
Disposition of aspirin and its metabolites in the semen of man. J Clin Pharmacol (1987) 0.82
Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats. J Pharmacol Exp Ther (1993) 0.81
I.V. lignocaine in reflex and allergic bronchoconstriction. Br J Anaesth (1980) 0.81
Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. J Pharmacol Exp Ther (1986) 0.81
The association between ankylosing spondylitis, acute anterior uveitis and HLA-B27: the results of a Swiss family study. Br J Rheumatol (1988) 0.81
Carpal involvement in inflammatory (erosive) osteoarthritis. J Can Assoc Radiol (1979) 0.81
Subcutaneous dacron and teflon cloth adjuncts for silastic arteriovenous shunts and peritoneal dialysis catheters. Trans Am Soc Artif Intern Organs (1968) 0.81
Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey. Pediatr Pharmacol (New York) (1980) 0.81
Hand radiographic changes in patients with primary and secondary Sjögren's syndrome. Scand J Rheumatol (1986) 0.81
Improved method for the determination of aspirin and its metabolites in biological fluids by high-performance liquid chromatography: applications to human and animal studies. J Chromatogr (1984) 0.81